Open AccessClinical significance of hepatitis B e antigen level easurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive
Author(s) -
Jüng Woo Shin,
Neung Hwa Park,
Seok Won Jung,
Byung Chul Kim,
Sung Ho Kwon,
Jae Serk Park,
In Du Jeong,
Sung-Jo Bang,
Do Ha Kim
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i41.6693
Subject(s) - hbeag , seroconversion , lamivudine , medicine , gastroenterology , chronic hepatitis , hepatitis b , immunology , hepatitis b virus , virus , hbsag
To determine the changes of quantitative hepatitis B e antigen (HBeAg) that predicts early detection of non-response or breakthrough to long-term lamivudine (LAM) therapy.